BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32352518)

  • 1. Spatial organization-dependent EphA2 transcriptional responses revealed by ligand nanocalipers.
    Verheyen T; Fang T; Lindenhofer D; Wang Y; Akopyan K; Lindqvist A; Högberg B; Teixeira AI
    Nucleic Acids Res; 2020 Jun; 48(10):5777-5787. PubMed ID: 32352518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA2 and ephrin-A5 are not a receptor-ligand pair in the ocular lens.
    Cheng C; Fowler VM; Gong X
    Exp Eye Res; 2017 Sep; 162():9-17. PubMed ID: 28648759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial control of membrane receptor function using ligand nanocalipers.
    Shaw A; Lundin V; Petrova E; Fördős F; Benson E; Al-Amin A; Herland A; Blokzijl A; Högberg B; Teixeira AI
    Nat Methods; 2014 Aug; 11(8):841-6. PubMed ID: 24997862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse roles of Eph/ephrin signaling in the mouse lens.
    Cheng C; Gong X
    PLoS One; 2011; 6(11):e28147. PubMed ID: 22140528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Universe of Eph Receptor and Ephrin Ligand Transcripts in Epithelial and Fiber Cells of the Eye Lens.
    Vu MP; Cheng C
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells.
    Cheng Q; Sasaki Y; Shoji M; Sugiyama Y; Tanaka H; Nakayama T; Mizuki N; Nakamura F; Takei K; Goshima Y
    Mol Cell Neurosci; 2003 Nov; 24(3):632-45. PubMed ID: 14664814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
    Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
    J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
    Xu Q; Lin WC; Petit RS; Groves JT
    Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further analysis of the lens of ephrin-A5-/- mice: development of postnatal defects.
    Son AI; Cooper MA; Sheleg M; Sun Y; Kleiman NJ; Zhou R
    Mol Vis; 2013; 19():254-66. PubMed ID: 23401654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epha2 and Efna5 participate in lens cell pattern-formation.
    Zhou Y; Shiels A
    Differentiation; 2018; 102():1-9. PubMed ID: 29800803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
    Jukonen J; Moyano-Galceran L; Höpfner K; Pietilä EA; Lehtinen L; Huhtinen K; Gucciardo E; Hynninen J; Hietanen S; Grénman S; Ojala PM; Carpén O; Lehti K
    Sci Rep; 2021 Apr; 11(1):8856. PubMed ID: 33893375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers.
    Singh DR; Pasquale EB; Hristova K
    Biochim Biophys Acta; 2016 Sep; 1860(9):1922-8. PubMed ID: 27281300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
    Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pinpointed Stimulation of EphA2 Receptors via DNA-Templated Oligovalence.
    Möser C; Lorenz JS; Sajfutdinow M; Smith DM
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2 Affects Development of the Eye Lens Nucleus and the Gradient of Refractive Index.
    Cheng C; Wang K; Hoshino M; Uesugi K; Yagi N; Pierscionek B
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):2. PubMed ID: 34978559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of receptor movement alters cellular response: physical force sensing by EphA2.
    Salaita K; Nair PM; Petit RS; Neve RM; Das D; Gray JW; Groves JT
    Science; 2010 Mar; 327(5971):1380-5. PubMed ID: 20223987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.
    Hahn AS; Desrosiers RC
    J Virol; 2014 Aug; 88(16):8724-34. PubMed ID: 24899181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.
    Saeki N; Nishino S; Shimizu T; Ogawa K
    Cell Adh Migr; 2015; 9(6):469-82. PubMed ID: 26565750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5.
    Forse GJ; Uson ML; Nasertorabi F; Kolatkar A; Lamberto I; Pasquale EB; Kuhn P
    PLoS One; 2015; 10(5):e0127081. PubMed ID: 25993310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
    Park JE; Son AI; Hua R; Wang L; Zhang X; Zhou R
    PLoS One; 2012; 7(5):e36564. PubMed ID: 22570727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.